Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Mar 18;9(2):1-14.
doi: 10.1120/jacmp.v9i2.2283.

Comparison of two treatment approaches for prostate cancer: intensity-modulated radiation therapy combined with 125I seed-implant brachytherapy or 125I seed-implant brachytherapy alone

Affiliations
Comparative Study

Comparison of two treatment approaches for prostate cancer: intensity-modulated radiation therapy combined with 125I seed-implant brachytherapy or 125I seed-implant brachytherapy alone

Yulin Song et al. J Appl Clin Med Phys. .

Abstract

The purpose of the present study was to assess the results of two different treatment approaches for clinically localized prostate cancer: intensity-modulated radiation therapy (IMRT) followed by 125I seed-implant brachytherapy and 125I seed-implant brachytherapy alone. We studied our 30 most recent consecutive patients. The sample population consisted of 15 cases treated with IMRT (50.4 Gy) followed by 125I seed-implant boost (95 Gy), and 15 cases treated with 125I seed implant only (144 Gy). We analyzed established dosimetric indices and various clinical parameters. In addition, we also evaluated and compared the acute urinary morbidities of the two treatment approaches, as assessed by the international prostate symptom score (IPSS). In our series, acute urinary morbidity was slightly increased with IMRT followed by 125I seed-implant brachytherapy as compared with 125I seed-implant brachytherapy alone. In addition, we observed no statistically significant correlation between the IPSS and the maximum or mean urethral dose. The combination of IMRT and seed-implant brachytherapy presents an alternative opportunity to treat clinically localized prostate cancer. The full potential of the procedure needs to be further investigated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Typical isodose distribution for a representative transverse slice of an intensity‐modulated radiation therapy plan. The red and green contours represent the planning target volume (PTV) and the urethra respectively. The maximum urethral dose was 100% of the prescribed dose, thus creating a circular low‐dose region around the urethra.
Figure 2
Figure 2
The 95‐Gy prescription isodose line (green) for a representative seed implant plan computed for the patient shown in Fig. 1. The pink squares indicate needles used for seed deposition. Three seeds were implanted in this particular slice, as indicated by three small white dots.

Similar articles

Cited by

References

    1. United States, National Institutes of Health (NIH), National Cancer Institute (NCI) . Prostate cancer progress report: addressing the recommendations of the prostate cancer progress review group. Washington (DC): U.S. Department of Health and Human Services, NIH, NCI; 2004. 5 pp.
    1. Barbiere J, Hanley J, Song Y, Dhaman AP, Chan MF. Concise matrix analysis of point‐based prostate targeting for intensity modulated radiation therapy. Technol Cancer Res Treat. 2007; 6 (1): 1–10. - PubMed
    1. Leibel SA, Fuks Z, Zelefsky MJ, et al. Technological advances in external‐beam therapy for the treatment of localized prostate cancer. Semin Oncol. 2003; 30 (5): 596–615. - PubMed
    1. Eng TY, Thomas CR Jr, Herman TS. Primary radiation therapy for localized prostate cancer. Urol Oncol. 2002; 7 (6): 239–257. - PubMed
    1. Zelefsky MJ, Whitmore WF Jr. Long‐term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol. 1997; 158 (1): 23–29. - PubMed

Publication types

Substances